Retrospective Evaluation of the Use of Pembrolizumab in Malignant Mesothelioma in a Real-World Australian Population-Reference-Cited by-同舟云学术

Retrospective Evaluation of the Use of Pembrolizumab in Malignant Mesothelioma in a Real-World Australian Population

Published:2020-11 Issue:4 Volume:1 Page:100075
ISSN:2666-3643
Container-title:JTO Clinical and Research Reports
language:en
Short-container-title:JTO Clinical and Research Reports

Author:

Ahmadzada Tamkin,Cooper Wendy A.,Holmes Mikaela,Mahar Annabelle,Westman Helen,Gill Anthony J.,Nordman Ina,Yip Po Yee,Pal Abhijit,Zielinski Rob,Pavlakis Nick,Nagrial Adnan,Daneshvar Dariush,Brungs Daniel,Karikios Deme,Aleksova Vesna,Burn Juliet,Asher Rebecca,Grau Georges E.,Hosseini-Beheshti Elham,Reid Glen,Clarke Stephen,Kao Steven

Funder

Bayer

Pfizer

Biaggio Signorelli Asbestos Foundation

The University of Sydney

Publisher

Elsevier BV

Reference49 articles.

1. Mesothelioma in Australia: a review;Musk;Med J Aust,2017

2. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma;Vogelzang;J Clin Oncol,2003

3. Bevacizumab for newly diagnosed pleural mesothelioma in the mesothelioma Avastin cisplatin pemetrexed Study (MAPS): a randomised, controlled, open-label, phase 3 trial;Zalcman;Lancet,2016

4. Immune checkpoint inhibition for the treatment of mesothelioma;Nowak;Expert Opin Biol Ther,2019

5. Use of immune checkpoint inhibitors in mesothelioma;Forde;Curr Treat Options Oncol,2019

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Outcome prediction based on [18F]FDG PET/CT in patients with pleural mesothelioma treated with ipilimumab and nivolumab +/- UV1 telomerase vaccine;European Journal of Nuclear Medicine and Molecular Imaging;2024-08-12

2. Malignant Pleural Mesothelioma: Socioeconomic and Clinical Aspects;Current Cancer Therapy Reviews;2024-07-23

3. Real‐world experience of immune checkpoint inhibitors in patients with solid tumours in the Top End of the Northern Territory, Australia from 2016 to 2021: a retrospective observational cohort study;Internal Medicine Journal;2024-07-05

4. Real‐world outcomes for patients with pleural mesothelioma: A multisite retrospective cohort study;Asia-Pacific Journal of Clinical Oncology;2024-06-21

5. Diffuse Pleural Mesotheliomas with Genomic Near-Haploidization: A Newly Recognized Subset with Distinct Clinical, Histologic, and Molecular Features;Clinical Cancer Research;2024-04-17